1170628

AcelRx Pharmaceuticals, Inc. — FEI 3006386491

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hayward, CA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)